APA (7th ed.) Citation

Akizawa, T., Origasa, H., Kameoka, C., Kaneko, Y., & Kanoh, H. (2014). Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study. Therapeutic apheresis and dialysis, 18(S2), 24-32. https://doi.org/10.1111/1744-9987.12202

Chicago Style (17th ed.) Citation

Akizawa, Tadao, Hideki Origasa, Chisato Kameoka, Yuichiro Kaneko, and Hiroyuki Kanoh. "Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study." Therapeutic Apheresis and Dialysis 18, no. S2 (2014): 24-32. https://doi.org/10.1111/1744-9987.12202.

MLA (9th ed.) Citation

Akizawa, Tadao, et al. "Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study." Therapeutic Apheresis and Dialysis, vol. 18, no. S2, 2014, pp. 24-32, https://doi.org/10.1111/1744-9987.12202.